242 related articles for article (PubMed ID: 23022070)
21. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM
J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442
[TBL] [Abstract][Full Text] [Related]
22. Condensation of delta-1-piperideine-6-carboxylate with ortho-aminobenzaldehyde allows its simple, fast, and inexpensive quantification in the urine of patients with antiquitin deficiency.
Boehm T; Hubmann H; Petroczi K; Mathis D; Klavins K; Fauler G; Plecko B; Struys E; Jilma B
J Inherit Metab Dis; 2020 Jul; 43(4):891-900. PubMed ID: 31930735
[TBL] [Abstract][Full Text] [Related]
23. Clinical and biochemical outcome of a patient with pyridoxine-dependent epilepsy treated by triple therapy (pyridoxine supplementation, lysine-restricted diet, and arginine supplementation).
Minet P; Sarret C; Miret A; Mention K; Benoist JF; Remerand G
Acta Neurol Belg; 2021 Dec; 121(6):1669-1675. PubMed ID: 33113107
[TBL] [Abstract][Full Text] [Related]
24. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).
Mills PB; Footitt EJ; Mills KA; Tuschl K; Aylett S; Varadkar S; Hemingway C; Marlow N; Rennie J; Baxter P; Dulac O; Nabbout R; Craigen WJ; Schmitt B; Feillet F; Christensen E; De Lonlay P; Pike MG; Hughes MI; Struys EA; Jakobs C; Zuberi SM; Clayton PT
Brain; 2010 Jul; 133(Pt 7):2148-59. PubMed ID: 20554659
[TBL] [Abstract][Full Text] [Related]
25. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.
Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR
Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477
[TBL] [Abstract][Full Text] [Related]
26. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.
Pérez B; Gutiérrez-Solana LG; Verdú A; Merinero B; Yuste-Checa P; Ruiz-Sala P; Calvo R; Jalan A; Marín LL; Campos O; Ruiz MÁ; San Miguel M; Vázquez M; Castro M; Ferrer I; Navarrete R; Desviat LR; Lapunzina P; Ugarte M; Pérez-Cerdá C
Epilepsia; 2013 Feb; 54(2):239-48. PubMed ID: 23350806
[TBL] [Abstract][Full Text] [Related]
27. Pyridoxine-dependent epilepsy due to antiquitin deficiency: achieving a favourable outcome.
Oliveira R; Pereira C; Rodrigues F; Alfaite C; Garcia P; Robalo C; Fineza I; Gonçalves O; Struys E; Salomons G; Jakobs C; Diogo L
Epileptic Disord; 2013 Dec; 15(4):400-6. PubMed ID: 24184718
[TBL] [Abstract][Full Text] [Related]
28. The Effects of a Single Oral Dose of Pyridoxine on Alpha-Aminoadipic Semialdehyde, Piperideine-6-Carboxylate, Pipecolic Acid, and Alpha-Aminoadipic Acid Levels in Pyridoxine-Dependent Epilepsy.
Wang J; Xue J; Gong P; Wu M; Yang W; Jiang S; Wu Y; Jiang Y; Zhang Y; Yuzyuk T; Li H; Yang Z
Front Pediatr; 2019; 7():337. PubMed ID: 31508398
[No Abstract] [Full Text] [Related]
29. Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE).
Pena IA; Marques LA; Laranjeira ÂB; Yunes JA; Eberlin MN; MacKenzie A; Arruda P
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):121-128. PubMed ID: 27615426
[TBL] [Abstract][Full Text] [Related]
30. Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS.
Jung S; Tran NT; Gospe SM; Hahn SH
Mol Genet Metab; 2013 Nov; 110(3):237-40. PubMed ID: 23953072
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and genetic characteristics and detection of urinary pipecolic acid in pyridoxine dependent epilepsy].
Xue J; Yang ZX; Li H; Qian P; Wu Y; Jiang YW; Liu XY
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):592-6. PubMed ID: 27510871
[TBL] [Abstract][Full Text] [Related]
32. Novel homozygous missense mutation in ALDH7A1 causes neonatal pyridoxine dependent epilepsy.
Coci EG; Codutti L; Fink C; Bartsch S; Grüning G; Lücke T; Kurth I; Riedel J
Mol Cell Probes; 2017 Apr; 32():18-23. PubMed ID: 27856333
[TBL] [Abstract][Full Text] [Related]
33. Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels.
Bok LA; Struys E; Willemsen MA; Been JV; Jakobs C
Arch Dis Child; 2007 Aug; 92(8):687-9. PubMed ID: 17088338
[TBL] [Abstract][Full Text] [Related]
34. The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy.
Bok LA; Maurits NM; Willemsen MA; Jakobs C; Teune LK; Poll-The BT; de Coo IF; Toet MC; Hagebeuk EE; Brouwer OF; van der Hoeven JH; Sival DA
Epilepsia; 2010 Dec; 51(12):2406-11. PubMed ID: 20887371
[TBL] [Abstract][Full Text] [Related]
35. Lysine-Restricted Diet as Adjunct Therapy for Pyridoxine-Dependent Epilepsy: The PDE Consortium Consensus Recommendations.
van Karnebeek CD; Stockler-Ipsiroglu S; Jaggumantri S; Assmann B; Baxter P; Buhas D; Bok LA; Cheng B; Coughlin CR; Das AM; Giezen A; Al-Hertani W; Ho G; Meyer U; Mills P; Plecko B; Struys E; Ueda K; Albersen M; Verhoeven N; Gospe SM; Gallagher RC; Van Hove JK; Hartmann H
JIMD Rep; 2014; 15():1-11. PubMed ID: 24748525
[TBL] [Abstract][Full Text] [Related]
36. Pyridoxine-dependent epilepsy owing to antiquitin deficiency--mutation in the ALDH7A1 gene.
Jagadeesh S; Suresh B; Murugan V; Suresh S; Salomans GS; Struys EA; Jacobs C
Paediatr Int Child Health; 2013 May; 33(2):113-5. PubMed ID: 23925287
[TBL] [Abstract][Full Text] [Related]
37. Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy.
Tseng LA; Abdenur JE; Andrews A; Aziz VG; Bok LA; Boyer M; Buhas D; Hartmann H; Footitt EJ; Grønborg S; Janssen MCH; Longo N; Lunsing RJ; MacKenzie AE; Wijburg FA; Gospe SM; Coughlin CR; van Karnebeek CDM
Mol Genet Metab; 2022 Apr; 135(4):350-356. PubMed ID: 35279367
[TBL] [Abstract][Full Text] [Related]
38. Current knowledge for pyridoxine-dependent epilepsy: a 2016 update.
Pena IA; MacKenzie A; Van Karnebeek CDM
Expert Rev Endocrinol Metab; 2017 Jan; 12(1):5-20. PubMed ID: 30058881
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy.
Crowther LM; Poms M; Zandl-Lang M; Abela L; Hartmann H; Seiler M; Mathis D; Plecko B
J Inherit Metab Dis; 2023 Jan; 46(1):129-142. PubMed ID: 36225138
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
